Received Mar 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z011893 | IM / RA |
Red, warm diffuse rash that appears to be an injection site reaction that started approximately 48 hours post-injection. Itched on day 2, but does not itch today, 72 hours post-injection, and no signs of fever. Patient reports rash is less red than yesterday and has no defined border or streaking. Rash not fully resolved but appears to be improving.
PCOS, hyperlipidemia, depression, Class III obesity
Tirzepatide (Zepbound) 2.5 mg injected under the skin once a week on Sundays.
No known drug or food allergies noted by patient.
none yet - messaging PCP for further guidance, but this dose completed the series.